Increased electron paramagnetic resonance signal correlates with mitochondrial dysfunction and oxidative stress in an Alzheimer's disease mouse brain

Journal of Alzheimer's Disease

Volumn 51, Issue 2, 2016, Pages 571-580

  Fang, Du ^a   Zhang, Zhihua ^a,c   Li, Hang ^c   Yu, Qing ^a,d   Douglas, Justin T ^b   Bratasz, Anna ^e   Kuppusamy, Periannan ^f   Yan, Shirley ShiDu ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c BEIJING NORMAL UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

^e OHIO STATE UNIVERSITY   (United States)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

A accumulation; cognitive function; mitochondrial dysfunction; oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; CYTOCHROME C OXIDASE; REACTIVE OXYGEN METABOLITE; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ANALYSIS; BRAIN CORTEX; BRAIN TISSUE; CELL FUNCTION; CELL LEVEL; CEREBELLUM; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; ELECTRON SPIN RESONANCE; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; FUNCTIONAL NEUROIMAGING; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; IMAGING SOFTWARE; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; MALE; MEMORY DISORDER; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROMETER; OXIDATIVE STRESS; PRIORITY JOURNAL; SPATIAL LEARNING; SWIMMING; ANIMAL; BRAIN; DIAGNOSTIC IMAGING; DISEASE MODEL; GENETICS; MAZE TEST; METABOLISM; MITOCHONDRION; ONSET AGE; PHYSIOLOGY; SPATIAL MEMORY; TRANSGENIC MOUSE;

ADENOSINE TRIPHOSPHATE; AGE OF ONSET; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; COGNITION; DISEASE MODELS, ANIMAL; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELECTRON TRANSPORT COMPLEX IV; FEMALE; HUMANS; MALE; MAZE LEARNING; MICE, TRANSGENIC; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SPATIAL MEMORY;

EID: 84961825661     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150917     Document Type: Article

References (67)

1. Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. (2015). The genetic landscape of Alzheimer disease: Clinical implications and perspectives. Genet Med. doi: 10.1038/gim.2015.117
2. Fang D, Wang Y, Zhang Z, Du H, Yan S, Sun Q, Zhong C, Wu L, Vangavaragu JR, Yan S, Hu G, Guo L, Rabinowitz M, Glaser E, Arancio O, Sosunov AA, McKhann GM, Chen JX, Yan SS. (2015). Increased neuronal PreP activity reduces Abeta accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model. Hum Mol Genet 24, 5198-5210.
3. Lin MT, Beal MF. (2006). Alzheimer's APP mangles mitochondria. Nat Med 12, 1241-1243.
4. Alikhani N, Guo L, Yan S, Du H, Pinho CM, Chen JX, Glaser E, Yan SS. (2011). Decreased proteolytic activity of the mitochondrial amyloid-beta degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria. J Alzheimers Dis 27, 75-87.
5. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD. (2008). Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 14, 1097-1105.
6. Casado A, Encarnacion Lopez-Fernandez M, Concepcion Casado M, De La Torre R. (2008). Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 33, 450-458.
7. Cristalli DO, Arnal N, Marra FA, De Alaniz MJ, Marra CA. (2012). Peripheral markers in neurodegenerative patients and their first-degree relatives. J Neurol Sci 314, 48-56.
8. Sinclair AJ, Bayer AJ, Team M, Johnston J, Warner C, Maxwell SRJ. (1998). Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. Int J Geriat Psychiatry 13, 840-845.
9. Ihara Y, Hayabara T, Sasaki K, Fujisawa Y, Kawada R, Yamamoto T, NakashimaY, Yoshimune S, KawaiM, Kibata M, Kuroda S. (1997). Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia. J Neurol Sci 153, 76-81.
10. Enns GM, Kinsman SL, Perlman SL, Spicer KM, Abdenur JE, Cohen BH, Amagata A, Barnes A, Kheifets V, Shrader WD, Thoolen M, Blankenberg F, Miller G. (2012). Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Mol Genet Metab 105, 91-102.
11. Drummond GR, Selemidis S, Griendling KK, Sobey CG. (2011). Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10, 453-471.
12. Karunakaran U, Park KG. (2013). A systematic review of oxidative stress and safety of antioxidants in diabetes: Focus on islets and their defense. Diabetes Metab J 37, 106-112.
13. McCarty MF, Barroso-Aranda J, Contreras F. (2010). Oxidative stress therapy for solid tumors - A proposal. Med Hypotheses 74, 1052-1054.
14. Jomova K, VondrakovaD, Lawson M, ValkoM(2010). Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345, 91-104.
15. Trifunovic A, Hansson A, WredenbergA, RovioAT, Dufour E, Khvorostov I, Spelbrink JN, Wibom R, Jacobs HT, Larsson NG. (2005). Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci U S A 102, 17993-17998.
16. Moreira P, Honda K, Liu Q, Santos M, Oliveira C, Aliev G, Nunomura A, Zhu X, Smith M, Perry G. (2005). Oxidative stress: The old enemy in Alzheimer's disease Pathophysiology. Curr Alzheimer Res 2, 403-408.
17. Tong Y, ZhouW, Fung V, Christensen MA, Qing H, Sun X, Song W. (2005). Oxidative stress potentiates BACE1 gene expression and A- generation. J Neural Transm 112, 455-469.
18. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, Yan SS. (2010). Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 107, 18670-18675.
19. Kuppusamy P, Afeworki M, Shankar RA, Coffin D, Krishna MC, Hahn SM, Mitchell JB, Zweier JL. (1998). In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res 58, 1562-1568.
20. Kuppusamy P, Li H, IlangovanG, Cardounel AJ, Zweier JL, Yamada K, Krishna MC, Mitchell JB. (2002). Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 62, 307-312.
21. Gan X, Wu L, Huang S, Zhong C, Shi H, Li G, Yu H, Howard Swerdlow R, Xi Chen J, Yan SS. (2014). Oxidative stressmediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction. Free Radic Biol Med 75, 230-240.
22. Kuppusamy P, Zweier JL. (1996). A forward-subtraction procedure for removing hyperfine artifacts in electron paramagnetic resonance imaging. Magn Reson Med 35, 316-322.
23. Vorhees CV, Williams MT. (2006). Morris water maze: Procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1, 848-858.
24. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. (2000). High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 20, 4050-4058.
25. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD. (2005). Mitochondrial Abeta: A potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19, 2040-2041.
26. Arancio O, Zhang HP, Chen X, Lin C, Trinchese F, Puzzo D, Liu S, Hegde A, Yan SF, Stern A, Luddy JS, Lue LF, Walker DG, Roher A, Buttini M, Mucke L, Li W, Schmidt AM, Kindy M, Hyslop PA, Stern DM, Du Yan SS. (2004). RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J 23, 4096-4105.
27. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H. (2004). ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452.
28. Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, Trillat AC, Stern DM, Arancio O, Yan SS. (2005). ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J 19, 597-598.
29. Du H, Guo L, Zhang W, Rydzewska M, Yan S. (2011). Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model. Neurobiol Aging 32, 398-406.
30. Emoto MC, Sato-Akaba H, Hirata H, Fujii HG. (2014). Dynamic changes in the distribution and time course of blood-brain barrier-permeative nitroxides in the mouse head with EPR imaging: Visualization of blood flow in a mouse model of ischemia. Free Radic Biol Med 74, 222-228.
31. Article J, Shingo M, Ichiro K, Toyoshi I, Hajime N, HideoU. (2003). Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radic Res 37, 767-772.
32. Phumala N, Ide T, Utsumi H. (1999). Noninvasive evaluation of in vivo free radical reactions catalyzed by iron using in vivo ESR spectroscopy. Free Radic Biol Med 26, 1209-1217.
33. Yamada KI, Kuppusamy P, English S, Yoo J, Irie A, Subramanian S, Mitchell JB, Krishna MC. (2002). Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiol 43, 433-440.
34. Krstic D, Knuesel I. (2013). Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol 9, 25-34.
35. Castellani RJ, Perry G. (2014). The complexities of the pathology-pathogenesis relationship in Alzheimer disease. Biochem Pharmacol 88, 671-676.
36. Small SA, DuffK(2008). Linking Abeta and tau in late-onset Alzheimer's disease: A dual pathway hypothesis. Neuron 60, 534-542.
37. Shineman DW, Basi GS, Bizon JL, Colton CA, Greenberg BD, Hollister BA, Lincecum J, Leblanc GG, Lee LB, Luo F, Morgan D, Morse I, Refolo LM, Riddell DR, Scearce- Levie K, Sweeney P, Yrjanheikki J, Fillit HM. (2011). Accelerating drug discovery for Alzheimer's disease: Best practices for preclinical animal studies. Alzheimers Res Ther 3, 28.
38. Bradley MA, Xiong-Fister S, Markesbery WR, Lovell M.A. (2012). Elevated 4-hydroxyhexenal in Alzheimer's disease. (AD). progression. Neurobiol Aging 33, 1034-1044.
39. Praticò D, Lee VM-Y, Trojanowski JQ, Rokach J, Fitzgerald GA. (1998). Increased F2-isoprostanes in Alzheimer's disease - evidence for enhanced lipid peroxidation in vivo. FASEB J 12, 1777-1783.
40. Cardoso SM, Santana I, Swerdlow RH, Oliveira CR. (2004). Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J Neurochem 89, 1417-1426.
41. Holley AE, Cheeseman KH. (1993). Measuring free radical reactions in vivo. Br Med Bull 49, 494-505.
42. Kohen R, Nyska A. (2002). Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30, 620-650.
43. Reddy PH. (2008). Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med 10, 291-315.
44. Maurer I, Zierz S, Moller HJ. (2000). A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 21, 455-462.
45. Blass JP. (2000). The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome. Ann N Y Acad Sci 924, 170-183.
46. Sheehan JP, Swerdlow RH, Miller SW, Davis RE, Parks JK, Parker WD, Tuttle JB. (1997). Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J Neurosci 17, 4612-4622.
47. Valla J, Schneider L, NiedzielkoT, CoonKD, Caselli R, Sabbagh MN, Ahern GL, Baxter L, Alexander G, Walker DG, Reiman EM. (2006). Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion 6, 323-330.
48. Reddy PH, Beal MF. (2008). Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14, 45-53.
49. Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, Eckert A, Muller WE. (2007). Mitochondrial dysfunction: The first domino in brain aging and Alzheimer's disease'. Antioxid Redox Signal 9, 1659-1675.
50. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE. (2009). Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 30, 1574-1586.
51. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. (2009). Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 106, 14670-14675.
52. Blass JP. (2003). Cerebrometabolic abnormalities in Alzheimer's disease. Neurol Res 25, 556-566.
53. Swerdlow RH, Khan SM. (2004). A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Med Hypotheses 63, 8-20.
54. Swerdlow RH, Khan SM. (2009). The Alzheimer's disease mitochondrial cascade hypothesis: An update. Exp Neurol 218, 308-315.
55. Chui DH, Dobo E, Makifuchi T, Akiyama H, Kawakatsu S, Petit A, Checler F, Araki W, Takahashi K, Tabira T. (2001). Apoptotic neurons in Alzheimer's disease frequently show intracellular Abeta42 labeling. J Alzheimers Dis 3, 231-239.
56. Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki H, Araki W, Inoue H, Shirotani K, Takahashi K, Gallyas F, Tabira T. (1999). Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med 5, 560-564.
57. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. (2003). Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
58. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L. (1999). Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96, 3228-3233.
59. Li QX, Maynard C, Cappai R, McLean CA, Cherny RA, Lynch T, Culvenor JG, Trevaskis J, Tanner JE, Bailey KA, Czech C, Bush AI, Beyreuther K, Masters CL. (1999). Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice. J Neurochem 72, 2479-2487.
60. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK. (2002). Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161, 1869-1879.
61. Reddy PH, McWeeney S, Park BS, Manczak M, Gutala RV, Partovi D, JungY, YauV, Searles R, Mori M, Quinn J. (2004). Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 13, 1225-1240.
62. Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell W Jr, Kaye J, Manczak M. (2005). Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction. J Alzheimers Dis 7, 103-117; discussion 173-180.
63. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith M.A. (2001). Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60, 759-767.
64. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. (2005). Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
65. Leissring MA, Farris W, Wu X, Christodoulou DC, Haigis MC, Guarente L, Selkoe DJ. (2004). Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria. Biochem J 383, 439-446.
66. Schildgen V, Wulfert M, Gattermann N. (2011). Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasiarelated changes. Exp Hematol 39, 666-675 e661.
67. Arthur CR, Morton SL, Dunham LD, Keeney PM, Bennett JP Jr. (2009). Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmicmtDNAmutation abundance. Mol Neurodegener 4, 37.